Soligenix to Advance Synthetic Hypericin Development in Psoriasis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. KBH
3. FDX
4. HONA
5. HTZ
6. HON
7. TTWO
8. HELP
9. GDYN
10. NKE

Go back to Soligenix to Advance Synthetic Hypericin Development in Psoriasis
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $4.35 
Open $0.38    52 Week Low $0.44 
Day High $0.38    P/E N/A 
Day Low $0.38    EPS $-0.81 
Volume 11,212